Skip to content
Events

Details

Illumina will be sponsoring Health Tech Spring 2025 at the The Titantic, Belfast from April 7th - 8th.  Come and visit us at booth 12, where you can meet our expert team to learn about our solutions and services on offer and discuss any requirements you may have.
Date & Time
7 Apr 2025 – 8 Apr 2025
Location
Titanic, Belfast
United Kingdom
Europe
Topic
Complex disease genomics, Genetic & rare diseases, Oncology, Pharmacogenomics, Precision health
This event has passed

Related Events

Apr 25
American Association for Cancer Research (AACR) Annual Meeting 2025
25 Apr 2025 – 30 Apr 2025
Join us at Illumina booth 800 to learn how Illumina is driving innovation in cancer research and clinical solutions.
View Event
Apr 28
Nordic Precision Medicine Forum
28 Apr 2025 – 29 Apr 2025
Illumina will be at Nordic Precision Medicine Forum , Illumina will be present across the whole event and through the event app to contact our team. ​ Discover how comphrensive genomic profiling can help to inform therapy decisions and see how Illumina can support your oncology workflow from sample-to-reporting .​ ​ Symposium: We’re pleased to announce that Illumina will be hosting our workshop at Nordic Precision Medicine Forum, “Liquid Biopsy Biomarkers for Cancer Research: Nation-wide Studies and Illumina Innovations ” on 28th April 16:00-17:00, Join us for an exciting overview of the applications of liquid biopsy-based biomarkers, insights into liquid biopsy testing and more! For more details please click here.
View Event
Apr 30
Rady’s Frontiers in Pediatric Genomic Medicine Conference 2025
30 Apr 2025 – 1 May 2025
Join Illumina at Rady’s 2025 Pediatric Genomics Conference to explore advances in rapid WGS and newborn screening breakthroughs.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.